hers semaglutide out of stock The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & to yank its new compounded (Wegovy) weight-loss pill from the Hims & Hers Health stock

Although many people see mood improvements on GLP-1s, others may struggle and find aspects of their lives not as rewarding or enticing as before, says Heinberg

(Exclusions may apply

Common symptoms include: Nausea and vomiting , particularly after meals or in the morning Early satiety feeling full after eating only small amounts of food Abdominal bloating and distension , often worsening throughout the day Upper abdominal discomfort or pain Heartburn or acid reflux due to prolonged retention of stomach contents Loss of appetite and unintentional weight loss beyond expected therapeutic effects Fluctuating blood glucose levels , as unpredictable gastric emptying affects carbohydrate absorption For most patients on Ozempic, mild to moderate gastrointestinal symptoms are transient and manageable, typically occurring during the initial weeks of treatment or following dose increases

Readers - what are your thoughts on GLP-1 receptor agonists for Alzheimers disease

Most compounding pharmacies recommend using opened vials within 28-30 days when stored in the refrigerator